These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

4407 related items for PubMed ID: 2646021

  • 1. Tumor progression in melanoma: the biology of epidermal melanocytes in vitro.
    Mancianti ML, Herlyn M.
    Carcinog Compr Surv; 1989; 11():369-86. PubMed ID: 2646021
    [Abstract] [Full Text] [Related]

  • 2. Tumor progression in the human melanocytic system.
    Kath R, Rodeck U, Menssen HD, Mancianti ML, Linnenbach AJ, Elder DE, Herlyn M.
    Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
    [Abstract] [Full Text] [Related]

  • 3. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE, Rodeck U, Thurin J, Cardillo F, Clark WH, Stewart R, Herlyn M.
    Cancer Res; 1989 Sep 15; 49(18):5091-6. PubMed ID: 2548711
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
    Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH.
    Cancer Res; 1985 Nov 15; 45(11 Pt 2):5670-6. PubMed ID: 4053039
    [Abstract] [Full Text] [Related]

  • 5. Phenotypic characteristics of cells derived from precursors of human melanoma.
    Herlyn M, Herlyn D, Elder DE, Bondi E, LaRossa D, Hamilton R, Sears HF, Balaban G, Guerry D, Clark WH.
    Cancer Res; 1983 Nov 15; 43(11):5502-8. PubMed ID: 6616481
    [Abstract] [Full Text] [Related]

  • 6. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U, Kilian U, Henkel U, Schaarschmidt H, Knopf B.
    Anticancer Res; 1991 Nov 15; 11(4):1405-14. PubMed ID: 1746897
    [Abstract] [Full Text] [Related]

  • 7. Biology of tumor progression in human melanocytes.
    Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H.
    Lab Invest; 1987 May 15; 56(5):461-74. PubMed ID: 3553733
    [Abstract] [Full Text] [Related]

  • 8. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H, Baril P, Tabone E, Bérard F, Sanhadji K, Balme B, Wolf F, Perrot H, Thomas L.
    Cancer Res; 2000 Oct 15; 60(20):5848-56. PubMed ID: 11059782
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.
    Bordoni R, Fine R, Murray D, Richmond A.
    J Cell Biochem; 1990 Dec 15; 44(4):207-19. PubMed ID: 2095366
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T, Stolz W, Welsh J, Jung B, Kerbel RS, Kobayashi H, Landthaler M, McClelland M.
    Clin Cancer Res; 1998 Mar 15; 4(3):791-7. PubMed ID: 9533549
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D, Alexander MA, Elder DE, Herlyn MF.
    J Immunol; 1987 Jul 01; 139(1):305-12. PubMed ID: 3108402
    [Abstract] [Full Text] [Related]

  • 12. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
    Herlyn M, Guerry D, Koprowski H.
    J Immunol; 1985 Jun 01; 134(6):4226-30. PubMed ID: 2985706
    [Abstract] [Full Text] [Related]

  • 13. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, Old LJ.
    Cancer Res; 1985 Sep 01; 45(9):4401-11. PubMed ID: 4028024
    [Abstract] [Full Text] [Related]

  • 14. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells.
    Herlyn M, Balaban G, Bennicelli J, Guerry D, Halaban R, Herlyn D, Elder DE, Maul GG, Steplewski Z, Nowell PC.
    J Natl Cancer Inst; 1985 Feb 01; 74(2):283-9. PubMed ID: 3856042
    [Abstract] [Full Text] [Related]

  • 15. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB, Mooi WJ, Le Poole IC, Van Muijen GN, Das PK.
    J Pathol; 2000 Apr 01; 190(5):572-8. PubMed ID: 10727983
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
    Ruiter DJ, Bergman W, Welvaart K, Scheffer E, van Vloten WA, Russo C, Ferrone S.
    Cancer Res; 1984 Sep 01; 44(9):3930-5. PubMed ID: 6204749
    [Abstract] [Full Text] [Related]

  • 17. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR, Rak J, Adachi D, Wiltshire R, Trent JM, Kerbel RS, Ben-David Y.
    Cancer Res; 1996 Jul 01; 56(13):3075-86. PubMed ID: 8674065
    [Abstract] [Full Text] [Related]

  • 18. Association between sialyl Lewis(a) expression and tumor progression in melanoma.
    Kageshita T, Hirai S, Kimura T, Hanai N, Ohta S, Ono T.
    Cancer Res; 1995 Apr 15; 55(8):1748-51. PubMed ID: 7712483
    [Abstract] [Full Text] [Related]

  • 19. Proliferation and morphology of melanoma cells and benign human melanocytes under varying culture conditions.
    Eberle J, Krasagakis K, Garbe C, Orfanos CE.
    Melanoma Res; 1993 Apr 15; 3(2):107-12. PubMed ID: 8518548
    [Abstract] [Full Text] [Related]

  • 20. Common acquired melanocytic nevi, melanocytic dysplasia and malignant melanoma. A morphometric study.
    Santucci M, Urso C, Giannini A, Bondi R.
    Appl Pathol; 1989 Apr 15; 7(2):111-5. PubMed ID: 2730799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 221.